Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency

被引:19
|
作者
Chinwong, Dujrudee [1 ,2 ]
Patumanond, Jayanton [3 ]
Chinwong, Surarong [1 ]
Siriwattana, Khanchai [4 ]
Gunaparn, Siriluck [5 ]
Hall, John Joseph [6 ]
Phrommintikul, Arintaya [5 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Pharmaceut Care, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Fac Med, Clin Epidemiol Program, Chiang Mai 50200, Thailand
[3] Thammasat Univ, Fac Med, Ctr Excellence Appl Epidemiol, Pathum Thani, Thailand
[4] Nakornping Hosp, Div Med, Chiang Mai, Thailand
[5] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50200, Thailand
[6] Univ Newcastle, Fac Hlth, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Callaghan, NSW 2308, Australia
关键词
LDL-C goal attainment; statins; potency statins; high risk; propensity score; LIPID-LOWERING TREATMENT; HIGH-RISK; HYPERCHOLESTEROLEMIC PATIENTS; LDL-C; MEDICATION ADHERENCE; CLINICAL-PRACTICE; PROPENSITY SCORE; ACHIEVEMENT; SIMVASTATIN; EZETIMIBE;
D O I
10.2147/TCRM.S75608
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Elevated low-density lipoprotein cholesterol (LDL-C) is associated with an increased risk of coronary artery disease. Current guidelines recommend an LDL-C target of <70 mg/dL (<1.8 mmol/L) for acute coronary syndrome (ACS) patients, and the first-line treatment to lower lipids is statin therapy. Despite current guidelines and the efficacious lipid-lowering agents available, about half of patients at very high risk, including ACS patients, fail to achieve their LDL-C goal. This study assessed LDL-C goal attainment according to use of high and low potency statins in routine practice in Thailand. Methods: A retrospective cohort study was performed by retrieving data from medical records and the electronic hospital database for a tertiary care hospital in Thailand between 2009 and 2011. Included were ACS patients treated with statins at baseline and with follow-up of LDL-C levels. Patients were divided into high or low potency statin users, and the proportion reaching the LDL-C goal of. 70 mg/dL was determined. A Cox proportional hazard model was applied to determine the relationship between statin potency and LDL-C goal attainment. Propensity score adjustment was used to control for confounding by indication. Results: Of 396 ACS patients (60% males, mean age 64.3 +/- 11.6 years), 229 (58%) were treated with high potency statins and 167 (42%) with low potency statins. A quarter reached their target LDL-C goal (25% for patients on high potency statins and 23% on low potency statins). High potency statins were not associated with increased LDL-C goal attainment (adjusted hazards ratio 1.22, 95% confidence interval 0.79-1.88; P=0.363). Conclusion: There was no significant effect of high potency statins on LDL-C goal attainment. Moreover, this study showed low LDL-C goal attainment for patients on either low or high potency statins. The reasons for the low LDL-C goal attainment rate warrants further investigation.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 50 条
  • [21] Effectiveness of statin therapy for elderly acute myocardial infarction patients with normal levels of low-density lipoprotein cholesterol
    Yamanaka, Futoshi
    Jeong, Myung Ho
    Saito, Shigeru
    Ahn, Youngkeun
    Chae, Shung Chull
    Hur, Seung Ho
    Hong, Taek Jong
    Kim, Young Jo
    Seong, In Whan
    Chae, Jei Keon
    Rhew, Jay Young
    Chae, In Ho
    Cho, Myeong Chan
    Bae, Jang Ho
    Rha, Seung Woon
    Kim, Chong Jin
    Choi, Donghoon
    Jang, Yang Soo
    Yoon, Junghan
    Chung, Wook Sung
    Cho, Jeong Gwan
    Seung, Ki Bae
    Park, Seung Jung
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (01) : 139 - 143
  • [22] Low-density lipoprotein cholesterol levels on admission and long-term outcomes in statin-naive patients with acute coronary syndrome
    Satou, R.
    Matsuzawa, Y.
    Akiyama, E.
    Konishi, M.
    Yoshii, T.
    Okada, K.
    Maejima, N.
    Iwahashi, N.
    Hibi, K.
    Kosuge, M.
    Ebina, T.
    Tamura, K.
    Kimura, K.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1647 - 1647
  • [23] The future of low-density lipoprotein cholesterol lowering therapy: An end to statin exceptionalism?
    Khera, Amit V.
    Natarajan, Pradeep
    Kathiresan, Sekar
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (10) : 1062 - 1064
  • [24] Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study
    Zhao, Yuqi
    Zhou, Ying
    Zhou, Huan
    Gong, Xiaoxian
    Luo, Zhongyu
    Li, Jiaping
    Sun, Jianzhong
    Lou, Min
    Yan, Shenqiang
    NEUROIMAGE-CLINICAL, 2023, 39
  • [25] Impact of statin therapy on EVT for PAD with decreased low-density lipoprotein cholesterol
    Noto, T.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2910 - 2910
  • [26] LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS, STATIN THERAPY, AND THE INCIDENCE OF PLAQUE RUPTURE
    Kurihara, Osamu
    Kim, Hyung Oh
    Russo, Michele
    Araki, Makoto
    Nakajima, Akihiro
    Lee, Hang
    Takano, Masamichi
    Mizuno, Kyoichi
    Jang, Ik-Kyung
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 84 - 84
  • [27] Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence
    Citarella, Anna
    Linder, Marie
    Kieler, Helle
    Berglind, Ingegard Anveden
    Sundstrom, Anders
    Wettermark, Bjorn
    Andersen, Morten
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (03) : 349 - 357
  • [28] Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence
    Anna Citarella
    Marie Linder
    Helle Kieler
    Ingegärd Anveden Berglind
    Anders Sundström
    Björn Wettermark
    Morten Andersen
    European Journal of Clinical Pharmacology, 2016, 72 : 349 - 357
  • [29] Statin Prescribing, Switching, and Low-density Lipoprotein Cholesterol Goal Attainment Across Racial/Ethnic Groups With Atherosclerotic Cardiovascular Disease
    Romanelli, Robert J.
    Ito, Matthew J.
    Karalis, Dean G.
    Huang, Hsiao-Ching
    Iorga, Serban R.
    Kam, Ivy
    Thompson, Stephen F.
    Azar, Kristen M.
    CIRCULATION, 2019, 139
  • [30] Low-Density Lipoprotein Cholesterol and Coronary Heart Disease: The Importance of Reaching Target Goals with Statin Therapy
    Lewis, Sandra J.
    JOURNAL OF FAMILY PRACTICE, 2009, 58 (11): : S32 - S40